BOSTON--(BUSINESS WIRE)--Pharmarama, a leader in the procurement of pharmaceutical products for comparator trials and named patient programs, today announced the opening of its U.S. office to facilitate overseas clinical and commercial development programs for North American life sciences companies. Among other benefits, the new office will enable U.S. pharmaceutical and biotechnology companies to leverage Pharmarama’s expertise in sourcing comparator drugs for human studies in regions including Central and Eastern Europe and Asia. In addition, the firm will help these companies supply as-yet unlicensed or experimental drugs for seriously ill patients living in countries where no suitable approved treatment exists.
